ZEAL:CPH
Zealand Pharma A/S
229,20 DKK
arrow_downward
-0,91%(-2,10) 1D
14 қаз., 13:07:53 GMT+2 · DKK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ZEAL...
Open
232,00 DKK
High
234,60 DKK
Low
227,40 DKK
Mkt. cap
16,81 млрд
Avg. vol.
402,85 м.
Volume
141,79 м.
52-wk high
556,00 DKK
52-wk low
227,40 DKK
Shares outstanding
71,61 млн
No. of employees
578
Open
232,00 DKK
High
234,60 DKK
Low
227,40 DKK
Mkt. cap
16,81 млрд
Avg. vol.
402,85 м.
Volume
141,79 м.
52-wk high
556,00 DKK
52-wk low
227,40 DKK
Shares outstanding
71,61 млн
No. of employees
578
News stories
From web sources and news partners
Euronext Markets: Real-time Stock Market Data | live
·
14 сағат бұрын
Zealand Pharma, Generate strike AI obesity drug deal worth up to $1.2 billion
Investing.com Canada
·
14 сағат бұрын
Zealand Pharma partners with Generate on AI drug development By Investing.com
Investing.com Canada
·
14 сағат бұрын
Generate Biomedicines, Zealand Pharma form AI drug partnership By Investing.com
Stock Titan
·
14 сағат бұрын
Up to nearly $1.2B in milestones is tied to Generate's planned AI research on obesity drugs.
Profile
Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. The company's head office is situated in Søborg near Copenhagen, and it has close to 200 employees. In 2018, they opened a subsidiary in the US. Zealand Pharma forms part of the Danish-Swedish life science cluster Medicon Valley. Wikipedia
About Zealand Pharma A/S